Skip to Content

WATSON 152 8 mg (Rapaflo 8 mg)

Generic Name: silodosin

Pill with imprint WATSON 152 8 mg is White, Capsule-shape and has been identified as Rapaflo 8 mg. It is supplied by Allergan, Inc..

Rapaflo is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Rapaflo 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 152 8 mg

Rapaflo 8 mg WATSON 152 8 mg
Rapaflo 8 mg WATSON 152 8 mg
Rapaflo 8 mg WATSON 152 8 mg Front
Rapaflo 8 mg WATSON 152 8 mg Back
Rapaflo 8 mg WATSON 152 8 mg

Rapaflo

Generic Name
silodosin
Imprint
WATSON 152 8 mg
Strength
8 mg
Color
White
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Allergan, Inc.
National Drug Code (NDC)
52544-0152

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.